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The protein product of the c-Cbl proto-oncogene is prominently tyrosine phosphorylated in response to
insulin in 3T3-L1 adipocytes and not in 3T3-L1 fibroblasts. After insulin-dependent tyrosine phosphorylation,
c-Cbl specifically associates with endogenous c-Crk and Fyn. These results suggest a role for tyrosine-
phosphorylated c-Cbl in 3T3-L1 adipocyte activation by insulin. A yeast two-hybrid cDNA library prepared
from fully differentiated 3T3-L1 adipocytes was screened with full-length c-Cbl as the target protein in an
attempt to identify adipose-specific signaling proteins that interact with c-Cbl and potentially are involved in
its tyrosine phosphorylation in 3T3-L1 adipocytes. Here we describe the isolation and the characterization of
a novel protein that we termed CAP for c-Cbl-associated protein. CAP contains a unique structure with three
adjacent Src homology 3 (SH3) domains in the C terminus and a region showing significant sequence similarity
with the peptide hormone sorbin. Both CAP mRNA and proteins are expressed predominately in 3T3-L1
adipocytes and not in 3T3-L1 fibroblasts. CAP associates with c-Cbl in 3T3-L1 adipocytes independently of
insulin stimulation in vivo and in vitro in an SH3-domain-mediated manner. Furthermore, we detected the
association of CAP with the insulin receptor. Insulin stimulation resulted in the dissociation of CAP from the
insulin receptor. Taken together, these data suggest that CAP represents a novel c-Cbl binding protein in
3T3-L1 adipocytes likely to participate in insulin signaling.
The mitogenic and metabolic effects of insulin are initiated
by the tyrosine kinase activity of its receptor. Upon insulin
binding, the insulin receptor undergoes autophosphorylation
on tyrosine residues, resulting in increased kinase activity that
leads to tyrosine phosphorylation of intracellular substrates
(34, 45). Since the tyrosine-phosphorylated insulin receptor
does not associate strongly with downstream Src homology 2
(SH2) domain-containing proteins, docking proteins are essen-
tial for insulin signaling. The tyrosine phosphorylation of these
proteins, which include the insulin receptor substrates 1 and 2
(IRS-1 and IRS-2), the Shc proto-oncogene product, and the
Grb2-associated protein GAB1, induces their association with
proteins containing SH2 domains, resulting in activation of
various signaling cascades (2, 7, 16, 24, 39, 40). Both IRS-1 and
Shc have been implicated in regulating the Ras signaling path-
ways and the downstream mitogenic actions of insulin (27, 32,
35, 36). Binding of phosphatidylinositol 39-kinase (PI 39-K) to
phosphorylated IRS-1 and IRS-2 leads to activation of the lipid
kinase in response to insulin (3, 7, 40). Although activation of
these known pathways are clearly important in insulin signal
transduction, recent studies have indicated that stimulation of
the mitogen-activated protein (MAP) kinase pathway and PI
39-K may not be sufficient for the stimulation of glucose trans-
port, lipid synthesis, or glycogen synthesis by insulin in 3T3-L1
adipocytes (19, 43, 46). These studies suggest that additional
signaling pathways may exist that are initiated by the tyrosine
phosphorylation of other substrates by the insulin receptor.
c-Cbl is the 120-kDa cellular homolog of the transforming
v-Cbl oncogene. The primary structure of c-Cbl resembles that
of DNA binding transcription factors, with a nuclear localiza-
tion sequence, a zinc finger-like motif, and a leucine zipper (5,
6). However, it is localized predominately in the cytoplasm,
while the truncated protein encoded by v-cbl is localized in
both the cytoplasm and the nucleus, where it can bind DNA
(6). c-Cbl becomes tyrosine phosphorylated in response to
activation of a variety of tyrosine kinases including v-Abl and
Bcr-Abl (1, 28); stimulation of the T- and B-cell antigen re-
ceptors (8, 11, 18), granulocyte-macrophage colony-stimulating
factor erythropoietin, Fc gamma receptors (21, 41), and the
epidermal growth factor (EGF) receptor (13, 15, 20); and
during integrin-mediated cell adhesion (22). These findings
suggest that c-Cbl may be an important component of signal
transduction downstream of tyrosine kinases. c-Cbl contains a
long proline-rich region in the COOH terminus that constitu-
tively binds the SH3 domains of the adapters Grb2 and Nck
and the Fyn and Lck tyrosine kinases independent of cell
activation (8, 11, 14, 21, 31). Upon cell activation, tyrosine-
phosphorylated c-Cbl binds the SH2 domains of Fyn, Lck, the
p85 subunit of PI 39-K, and c-Crk (8, 11, 13, 14, 18, 28, 37).
Moreover, the association of c-Crk with tyrosine-phosphory-
lated c-Cbl correlates well with cellular transformation in Bcr-
Abl or mutant, oncogenic c-Cbl (70Z)-expressing cells (28).
We reported recently that insulin markedly stimulated the
tyrosine phosphorylation of c-Cbl in 3T3-L1 adipocytes, induc-
ing its association with the adapter protein c-Crk and the Src
family kinase Fyn. Interestingly, insulin did not stimulate c-Cbl
tyrosine phosphorylation in 3T3-L1 fibroblasts or in any other
cell lines expressing high levels of functional insulin receptors
and c-Cbl (30). These results suggest a physiological function
for c-Cbl in insulin action in the metabolically responsive
3T3-L1 adipocytes. However, we did not detect the direct as-
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sociation of c-Cbl with the insulin receptor, suggesting that a
protein present in 3T3-L1 adipocytes but not in fibroblasts
plays a critical role in the tyrosine phosphorylation of c-Cbl by
the insulin receptor. We report here the isolation and the
characterization of a novel signaling protein that we termed
CAP for c-Cbl-associated protein. Both CAP mRNA and pro-
teins are expressed predominately in 3T3-L1 adipocytes and
not in 3T3-L1 fibroblasts. CAP interacts with both c-Cbl and
the insulin receptor in 3T3-L1 adipocytes and may have an
important function in the specificity of tyrosine phosphoryla-
tion events under the regulation of insulin.
MATERIALS AND METHODS
Yeast two-hybrid system. Full-length c-Cbl fused to the C terminus of the
GAL4 DNA binding domain in the yeast expression vector pGBT9 (Clontech)
was constructed from full-length human c-Cbl in the pGEM4Z vector (kindly
provided by L. E. Samelson). A 3T3-L1 adipocyte cDNA library was synthesized
with a cDNA synthesis kit (Stratagene) and constructed in the pGAD-GH GAL4
vector (Clontech). The yeast strain Y190 was first transformed to tryptophan
prototrophy with the GAL4-c-Cbl protein and then with the 3T3-L1 adipocyte
cDNA library. The resulting transformants were plated on selection medium
lacking tryptophan, leucine, and histidine and containing 25 mM 3-aminotriazole
and were incubated at 30°C for 4 to 5 days. His1 colonies were plated onto
M63GV-Trp-Leu-His medium containing 5-bromo-4-chloro-3-indolylphosphate-
b-D-galactopyranoside (X-Gal) (26) and were analyzed for b-galactosidase ac-
tivity. Library-derived plasmids were rescued from positive clones and were
transformed into Escherichia coli HB101 for DNA sequencing. Nucleotide and
amino acid sequence alignments were performed by screening GenBank and
EMBL databases with the BLAST program.
Cell culture and activation. 3T3-L1 fibroblasts were maintained in Dulbecco’s
modified Eagle’s medium (4,500 g of glucose/liter) supplemented with 10% fetal
bovine serum and 1% penicillin-streptomycin. Differentiation to adipocytes was
induced as previously described (33). The cells were then cultured in Dulbecco’s
modified Eagle’s medium containing 10% fetal bovine serum for 2 to 8 days.
Before hormonal treatment, the cells, grown in 10-cm-diameter dishes, were
serum deprived for 12 to 18 h. Unless otherwise indicated, 100 nM insulin
(Sigma) was added directly to the medium and the incubation was continued for
the indicated times at 37°C. Chinese hamster ovary (CHO) cells were cultured in
minimal Eagle’s medium containing nucleotides, 10% fetal bovine serum, and
1% penicillin-streptomycin.
Northern blot analysis. Total cellular RNA was isolated from 3T3-L1 fibro-
blasts and adipocytes by the acid guanidinium thiocyanate method (9). RNA
samples (20 mg) were fractionated in 1.2% agarose–2.2 M formaldehyde and
transferred to a Hybond-N membrane (Amersham). Hybridizations were per-
formed at 65°C for 20 h first with a purified EcoRI fragment from clone 2.1 (Fig.
1A) and then with a b-actin probe labeled with [a-32P]dCTP (Amersham) by the
random-primer extension method. A mouse multiple-tissue Northern blot anal-
ysis (Clontech) was performed with a clone 2.1 probe by following the manufac-
turer’s instructions.
Antibodies. For the production of anti-CAP antibodies, CAP clone 2.1 (Fig.
1A) was subcloned from the pGAD-GH plasmid into the EcoRI site of pGEX-
5X-3 vector (Pharmacia Biotechnology) to facilitate expression as a glutathione
S-transferase (GST) fusion protein. The GST-CAP-SH3 fusion protein was pu-
rified from bacterial cell lysates with glutathione-Sepharose beads and injected
into New Zealand rabbits according to standard procedure. To affinity purify the
resulting antiserum, GST-CAP-SH3 fusion protein adsorbed on the glutathione-
Sepharose beads was cleaved by incubation with Factor Xa (New England Bio-
Labs) in a buffer containing 20 mM HEPES (pH 8), 100 mM NaCl, and 2 mM
CaCl2 for 12 h at room temperature. After centrifugation to remove the beads,
the supernatant was incubated with benzamidine-Agarose (Sigma) for 15 min at
room temperature. The CAP-SH3 protein in the supernatant was then coupled
to an AminoLink column (Pierce, Rockford, Ill.) by following the instructions in
the manufacturer’s manual. The affinity-purified anti-CAP antibodies were sub-
jected to buffer exchange with Tris-buffered saline (10 mM Tris-HCl [pH 7.4],
150 mM NaCl), quantitated, and stored at 270°C. Anti-c-Cbl and anti-ERK2
antibodies were purchased from Santa Cruz Inc., anti-insulin receptor antibodies
and protein G- and protein A-Agarose were purchased from Oncogene Science,
and anti-c-Crk-II antibody and the antiphosphotyrosine antibody RC20H were
purchased from Transduction Laboratories. Anti-Flag antibodies were pur-
chased from Kodak, New Haven, Conn. Horseradish peroxidase-linked second-
ary antibodies were from Amersham.
Expression vector construct and transfection of CHO cells. A Flag epitope-
tagged full-length CAP in a eukaryotic expression vector was constructed as
follows. The cDNA of the amino-terminal region of CAP was amplified by PCR
with CAP cDNA in pEXlox as the template (38). The primer 59-CGCGGATC
CGCCGCCACCATGGAC TACAAGGACGACGATGACAAGAG T TC TGA
ATGTGAT-39 was designed to have a BamHI restriction site followed by a
coding sequence for a Flag epitope in frame with amino acid 2. The primer
59-AATGTCTGGAGTCGG-39 corresponds to amino acids 345 to 350. The
amplified DNA fragment was digested with BamHI and SacI (present in the CAP
gene) and ligated into CAP cDNA clone 2.5 (Fig. 1A) in the pGAD-GH vector
digested with BamHI and SacI. The Flag-tagged full-length CAP cDNA was then
liberated by digestion with SpeI and EcoRI and ligated into the PCI expression
vector (Promega) at the NheI and EcoRI sites. The sequence of the Flag-tagged
CAP cDNA (Flag-CAP) in this vector was confirmed by DNA sequencing.
CHO cells were transiently transfected with 10 mg of either Flag-CAP or the
vector alone with the Lipofectamine reagent (Gibco-BRL) for 4 h at 37°C. The
transfected cells were then washed twice with phosphate-buffered saline, and
complete medium was added. Forty-eight hours after transfection, the cells were
washed and lysed for further analysis.
Immunoprecipitations and immunoblotting. Cells (0.5 3 107 to 1 3 107) were
washed twice with ice-cold phosphate-buffered saline and lysed with buffer con-
taining 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% Triton X-100, 1 mM
EDTA, 10 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 100 mM
NaF, 10 mg of aprotinin/ml, 10 mg of leupeptin/ml, and 1 mM phenylmethylsul-
fonyl fluoride on ice for 15 min. After centrifugation at 10,000 3 g for 15 min at
4°C, the clarified supernatants were incubated with the indicated antibodies for
3 h at 4°C. The immune complexes were precipitated with protein G- or protein
A-Agarose for 2 h and were washed extensively with lysis buffer before solubi-
lization in Laemmli sample buffer. Bound proteins were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred
to nitrocellulose membranes. Individual proteins were detected with the speci-
fied antibodies and visualized by blotting with horseradish peroxidase-linked
secondary antibodies. To reprobe immunoblots, the nitrocellulose membranes
were incubated for 30 min at 60°C with 62.5 mM Tris-HCl (pH 6.8)–2% SDS–
0.7% 2-mercaptoethanol, and then were washed extensively with 10 mM Tris-
HCl (pH 8)–150 mM NaCl.
In vitro binding assays. The DNA fragments encoding the individual SH3
domains of CAP were generated by PCR with the following oligonucleotides
(which contain BamHI and EcoRI restriction sites): 59-CTGTGCGGATCCGG
ATTAGAGA-39 and 59-CTGTGCGAATTCCTCAGCTGGAGGAAGAAGCT
C-39 for SH3A, 59-CTGTGCGGATCCGAATATGGAGAAGCCATTGCA-39
and 59-CTGTGCGAATTCAAGCACATCTACATAGGT-39 for SH3B, and 59-
CTGTGCGGGATCCGATTTGTGTAGCTACCAAGCG-39 and 59-CTGTGC
GAATTCTTCTTATAGATATAAAGG-39 for SH3C. The amplification prod-
ucts were digested with BamHI and EcoRI and inserted in frame between the
homologous sites of the GST expression vector pGEX-2T (Pharmacia). All
FIG. 1. Primary structure of CAP and mRNA expression. (A) 3T3-L1 adi-
pocyte cDNA clones isolated from the yeast two-hybrid screen with c-Cbl as bait
are shown (black lines) aligned below a schematic of the domain organization of
the CAP protein. Numbers in parentheses refer to the number of times each
clone was isolated from the yeast two-hybrid screen. The letters A, B, and C
indicate the presence of alternative spliced inserts. (B) Total RNA (20 mg)
isolated from 3T3-L1 adipocytes or fibroblasts was hybridized to a probe pre-
pared from the DNA insert of clone 2.1 labeled with [a-32P]dCTP by random-
primer extension (upper). The filter was then stripped and rehybridized with a
b-actin probe to estimate the relative amount of RNA in each lane (lower). The
migration positions of RNA size markers (in kilobases) are on the left.
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constructs were verified by DNA sequencing through the entire portion obtained
by PCR. GST fusion proteins containing the SH2 and SH3 domains of Crk were
the generous gift of R. B. Birge and H. Hanafusa (4, 12). In vitro association
experiments were performed with an equal amount (5 mg) of the immobilized
GST-fusion proteins or GST alone as described previously (29). The bound
proteins were analyzed as described above for immunoprecipitates.
Cellular fractionation. 3T3-L1 adipocytes, treated with or without insulin (100
nM) for 5 min, were washed twice with ice-cold phosphate-buffered saline and
scraped into 1 ml of homogenization buffer containing 50 mM HEPES (pH 7.2),
2 mM EDTA, 2 mg of glycogen/ml, 0.2% 2-mercaptoethanol, 0.1 mM phenyl-
methylsulfonyl fluoride, 1 mM benzamidine, 10 mg of aprotinin, and 10 mg of
leupeptin/ml. Cells were sonicated and centrifuged at 2,500 3 g to remove nuclei
and unlysed cells. The postnuclear supernatant was removed and centrifuged for
15 min at 10,000 3 g to pellet the plasma membranes. The supernatant was
recentrifuged for 1 h at 100,000 3 g. The final supernatant was called cytosol.
The plasma membrane pellets were resuspended in homogenization buffer by 10
passes through a 23-gauge needle and recentrifuged. The final pellet was resus-
pended as described above. Proteins (25 mg) were separated by SDS-PAGE and
identified by immunoblotting with specific antibodies.
RESULTS
Isolation of a c-Cbl-binding protein with the yeast two-hy-
brid system. To elucidate the signaling pathways in which
c-Cbl is involved in 3T3-L1 adipocytes, we searched for adipo-
cyte-specific c-Cbl-interacting proteins. Towards this goal, full-
length c-Cbl fused to the DNA binding domain of GAL4
(GAL4-c-Cbl) was used as bait to screen a 3T3-L1 adipocyte
cDNA expression library fused to the GAL4 transcriptional
activation domain in the yeast two-hybrid interaction system.
Of 5 3 105 total transformants, 13 colonies were subsequently
positive for b-galactosidase activity when they were plated on
X-Gal-containing medium. The recovered library-derived plas-
mids induced b-galactosidase activity only when they were
coexpressed with GAL4-c-Cbl fusion protein and not with an
unrelated GAL4 fusion protein containing the catalytic do-
main of protein phosphatase 1.
DNA sequences from the GAL4 fusion junctions of all the
plasmid inserts revealed that they all encoded five independent
novel protein fragments overlapping at the COOH terminus
(Fig. 1A, clones 2.1, 2.2, 2.3, 2.4, and 2.5). We designated this
protein CAP for c-Cbl-associated protein. The open reading
frame of these cDNA inserts is followed by a stop codon and
250 bp of 39 untranslated region. A computer-assisted se-
quence homology search of GenBank revealed that the
COOH-terminal region of CAP contains three adjacent SH3
domains. A stretch of ;120 amino acids of CAP (Fig. 1A,
clones 2.4 and 2.5) has significant sequence similarity with the
porcine peptide hormone sorbin (32% identity at the amino
acid level [42]) and was termed the sorbin domain.
The cDNAs that encompass the complete coding region of
CAP have been isolated from a mouse embryo cDNA expres-
sion library by using a functional screen with a defined SH3
ligand peptide (38). The open reading frames of these cDNAs
contained insertions of a different sequence (types A to C) in
the middle of CAP, presumably due to alternative splicing
(Fig. 1A). Analysis of the coding sequences predicted proteins
with molecular masses of 77 to 90 kDa. The CAP clones iso-
lated by the two-hybrid screen had both the B and C type
insertions missing (Fig. 1A). The structure and the predicted
amino acid sequence of CAP suggest that it represents a family
of novel signaling molecules that may function as multi-domain
binding proteins.
Since CAP cDNA was isolated from a cDNA library pre-
pared from 3T3-L1 adipocytes, we determined the expression
pattern of the CAP gene in 3T3-L1 cells. Northern blot analysis
of RNA isolated from both 3T3-L1 fibroblasts and fully differ-
entiated adipocytes was performed with the cDNA insert of
clone 2.1. As shown in Fig. 1B, transcripts corresponding to a
major, broad band of 7 kb and a minor band of 8 kb were
detected in 3T3-L1 adipocytes. Interestingly, no mRNA was
detected in 3T3-L1 fibroblasts. CAP transcripts with the same
sizes were also detected in RNA isolated from rat adipocytes
(not shown).
Expression of CAP proteins during 3T3-L1 cell differentia-
tion. In order to characterize the proteins encoded by CAP,
polyclonal antibodies were raised against the purified C-termi-
nal domain of CAP present in clone 2.1 (Fig. 1A), expressed as
a GST fusion protein. For the expression of CAP in CHO cells,
CAP clone 2.5, isolated by the two-hybrid screen, was fused in
frame to the N-terminal region of CAP obtained from the
mouse embryo library. A plasmid containing this full-length
form of CAP, with a Flag epitope tagged onto the N terminus
(Flag-CAP), or the vector alone (PCI) was transiently trans-
fected into CHO cells. Lysates prepared from the transfected
cells were immunoprecipitated with antibodies to Flag (Anti-
Flag) or with anti-CAP antibodies. The immunoprecipitates
were separated by SDS-PAGE followed by immunoblotting
with anti-Flag antibodies. As shown in Fig. 2A, The N-terminal
Flag-tagged CAP was recognized by both the anti-Flag anti-
bodies and the anti-CAP serum elicited against the C terminus
FIG. 2. Identification of the CAP gene product(s). (A) CHO cells were
transiently transfected with an expression vector containing full-length CAP with
a Flag epitope tagged onto the N terminus (Flag-CAP) or the vector alone (PCI).
Cell lysates were then immunoprecipitated (IP) with anti-Flag or anti-CAP
antibodies. Whole-cell lysates (WCL) containing 20 mg of protein and the im-
munoprecipitates were subjected to SDS-PAGE and immunoblotted with anti-
Flag antibodies. (B) Cell lysates prepared from 3T3-L1 adipocytes or CHO cells
transfected with Flag-CAP were directly analyzed by immunoblotting with anti-
CAP antibodies. (C) Total cellular lysates prepared from confluent 3T3-L1
fibroblasts (Conf) and at various times during differentiation into adipocytes as
previously described (33) (30 mg per lane) were separated by SDS-PAGE fol-
lowed by immunoblotting with anti-CAP antibodies. Molecular mass markers (in
kilodaltons) are on the left. Diffe. Mix, differentiation mixture; FBS, fetal bovine
serum.
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of CAP. The protein encoded by this cDNA migrated as a
single band with an apparent molecular mass of 85 kDa on an
SDS-PAGE gel. Similar results were obtained following immu-
noblotting of the immunoprecipitates with the anti-CAP serum
(data not shown). Both antibodies detected CAP only in cell
lysates prepared from the CAP-transfected CHO cells and not
in cells transfected with the vector alone. CHO cells express no
detectable endogenous proteins recognized by the anti-CAP
antibodies. These results indicate that our antibodies specifi-
cally recognize the protein product of the cap gene.
We next examined the expression of CAP proteins in 3T3-L1
adipocytes (Fig. 2B). Interestingly, while in CHO cells the
anti-CAP antibodies detected only the product of the Flag-
tagged CAP cDNA, with similar results obtained with Flag-
tagged CAP-transfected NIH 3T3 cells (data not shown), the
anti-CAP antibodies detected several proteins in 3T3-L1 adi-
pocyte cell lysates. An adipocyte protein with a molecular mass
of 88 to 90 kDa migrated similarly to the CAP protein ex-
pressed in transfected CHO cells. The slower mobility of this
adipocyte protein might reflect posttranslational modifications
that do not occur in CHO cells. In addition to the 88-kDa
protein product, the anti-CAP antibodies also detected pro-
teins with molecular masses of 125, 75, 53, and 45 kDa with
different levels of expression in 3T3-L1 adipocyte lysates.
These proteins may represent different isoforms or alterna-
tively spliced variants of CAP expressed in 3T3-L1 adipocytes,
consistent with the identification of various cDNA splice forms
and mRNA transcripts. It is possible that the anti-CAP anti-
bodies were able to recognize multiple isoforms of CAP in
3T3-L1 adipocytes common in their C-terminal portion used
for antibody production. However, whether each of these pro-
teins is a distinct CAP isoform remains uncertain.
Since CAP mRNA was detected only in 3T3-L1 adipocytes
(Fig. 1B), we were interested to examine the expression pat-
tern of CAP at different stages during the conversion of
3T3-L1 fibroblasts into adipocytes. Equivalent amounts of pro-
tein, prepared from confluent 3T3-L1 preadipocytes and at
various times during differentiation into adipocytes, were sep-
arated by SDS-PAGE followed by immunoblotting with anti-
CAP antibodies (Fig. 2C). The 88-kDa CAP was undetectable
in confluent preadipocytes, while a low level of expression of
the 125-kDa protein was detected in the preadipocytes that
increased during differentiation. The 88-kDa CAP was de-
tected only 6 days after the initiation of differentiation (2 days
FBS), when lipid accumulation was just starting with an in-
crease to maximal expression after extensive differentiation.
Additionally, the proteins of 75, 53, and 45 kDa were detected
with anti-CAP antibodies only in fully differentiated 3T3-L1
cells. These results demonstrate that both CAP mRNA and
protein expression are largely restricted to 3T3-L1 adipocytes.
Tissue distribution of CAP. To determine the tissue distri-
bution of CAP mRNA, a mouse multiple-tissue Northern blot
was hybridized with a probe prepared from the DNA insert of
clone 2.1 (Fig. 3). Several size classes of CAP mRNA tran-
scripts were detected with tissue-specific variation in their rel-
ative abundance. CAP mRNA expression was highest in heart,
liver, skeletal muscle and kidney. Lesser amounts were de-
tected in brain and lung, while we could not detect CAP
mRNA in spleen and testis, even after long exposure. The
three most prominent CAP transcripts were approximately 6.5,
7.4, and 8 kb. Similar results were obtained when a rat multi-
ple-tissue Northern blot was hybridized with the same probe
(data not shown). These results are consistent with the isola-
tion of multiple CAP cDNA variants. These may be expressed
in a tissue-specific manner with distinct physiological functions.
The specific expression of CAP in adipose tissue as well as liver
and muscle makes CAP a candidate for a physiologically rel-
evant effector protein in insulin signaling.
Interactions of CAP SH3 domains. All of the activation
domain-fused CAP clones isolated by the yeast two-hybrid
screen contained all three SH3 domains, and one CAP clone
(2.1 [Fig. 1A]) contained exclusively the three SH3 domains.
This result suggested that the interaction of CAP with c-Cbl is
primarily mediated by the SH3 domains binding to the proline-
rich motifs in c-Cbl. To confirm that the SH3 domains of CAP
interact with native c-Cbl, and to address the effect of insulin
on this association, a GST fusion protein was generated with
the clone 2.1 coding region (CAP-SH3). We have recently
demonstrated that c-Cbl is rapidly tyrosine phosphorylated in
response to insulin 3T3-L1 adipocytes. On phosphorylation,
c-Cbl forms an insulin-dependent association with the SH2
domain of Crk (30). Lysates prepared from 3T3-L1 adipocytes
treated with or without insulin were incubated with the GST
fusion proteins containing Crk-SH2, CAP-SH3, or GST alone
immobilized on glutathione-Sepharose beads. The bound pro-
teins were separated by SDS-PAGE and were detected by
immunoblotting with anti-c-Cbl antibodies (Fig. 4A). GST-
CAP-SH3 fusion protein bound c-Cbl in lysates of unstimu-
lated cells. Treatment of cells with insulin had no effect on the
amount of c-Cbl associated with the GST-CAP-SH3 fusion
protein, while such treatment induced the association of c-Cbl
with GST-Crk-SH2. Thus, CAP and c-Cbl form a constitutive
complex in 3T3-L1 adipocytes independent of insulin stimula-
tion. The tyrosine phosphorylation of c-Cbl in response to
insulin does not regulate its interaction with CAP. These data
are in agreement with the two-hybrid experiments and empha-
size the role of CAP-SH3 domains in the interaction with
c-Cbl.
To define the interaction between CAP and c-Cbl in more
detail, each of the SH3 domains of CAP was expressed as a
GST fusion protein. Lysates prepared from 3T3-L1 adipocytes
stimulated with insulin or left untreated were incubated with
FIG. 3. Tissue distribution of CAP mRNA. A Northern blot containing
mouse poly(A1) RNA (2 mg per lane) from the indicated tissues was hybridized
with the cDNA insert of clone 2.1 probe. The positions of RNA size markers in
kilobases are shown on the left.
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GST fusion protein containing the individual SH3 domains of
CAP and the Crk-SH3 domain as a control. The bound pro-
teins were immunoblotted with anti-c-Cbl or anti-Sos antibod-
ies. As shown in Fig. 4B (anti-c-Cbl blot), the carboxyl-terminal
SH3 domain of CAP (SH3C) was able to bind c-Cbl in un-
stimulated 3T3-L1 adipocytes. As described above, insulin had
no effect on the association state of the CAP-SH3C–c-Cbl
complex. Immunoblotting the above-described bound proteins
with anti-Sos antibodies (Fig. 4B, anti-Sos blot) indicated that
the carboxyl-terminal SH3 domain of CAP (SH3C) may bind
Sos in lysates of unstimulated cells. Interestingly, similar to the
ability of insulin to induce the phosphorylation-dependent dis-
sociation of Grb2-Sos and to a lesser extent Crk-Sos complexes
(23, 44), there was an insulin-dependent dissociation of the
CAP-SH3C–Sos complex. The first SH3 domain (SH3A, clos-
est to the N terminus) and the middle SH3 domain (SH3B) did
not independently associate with either c-Cbl or Sos. However,
using a phage-displayed library, we identified peptide ligands
to each of the isolated SH3 domains of CAP, demonstrating
that these are functional SH3 domains (data not shown).
Association of CAP with c-Cbl and Sos in intact cells. The
association of CAP and c-Cbl were examined in CHO cells
transfected with Flag-CAP or the vector alone (PCI). Lysates
prepared from transfected CHO cells were immunoprecipi-
tated with anti-CAP or anti-Flag antibodies followed by im-
munoblotting with anti-c-Cbl antibodies (CHO cells express
endogenous c-Cbl). c-Cbl was coimmunoprecipitated with an-
ti-CAP or anti-Flag antibodies from Flag-CAP-transfected
CHO cell lysates but not from cells transfected with the vector
alone (Fig. 5A).
As the SH3 domain of CAP could also bind Sos in vitro, we
tested whether this association also occurs in cells. CHO cells
transfected with Flag-CAP were lysed followed by immunopre-
cipitation with anti-Sos antibodies. As shown in Fig. 5B, CAP
was immunoprecipitated with anti-Sos antibodies from the
transfected cells. These experiments indicated that CAP inter-
acts with c-Cbl and Sos to form stable complexes in intact cells
through binding of the CAP carboxy-terminal SH3 domain.
Endogenous CAP associates with c-Cbl in 3T3-L1 adipo-
cytes. To gain further insight regarding the functional impor-
tance of the c-Cbl-CAP association, we analyzed the associa-
tion of endogenous CAP and c-Cbl in intact 3T3-L1 adipocytes
and the effect of insulin stimulation on the in vivo interaction.
FIG. 4. c-Cbl binds to the carboxyl-terminal SH3 domain of CAP indepen-
dent of insulin stimulation. (A) 3T3-L1 adipocytes were serum starved for 18 h
and then stimulated with insulin (100 nM) for 5 min or left untreated. The cell
lysates were incubated with the GST fusion proteins containing Crk-SH2, the
three CAP SH3 domains (CAP-SH3), or GST alone immobilized on glutathione-
Sepharose beads for 90 min at 4°C. The bound proteins were eluted, resolved by
SDS-PAGE, and immunoblotted with anti-c-Cbl antibodies. (B) 3T3-L1 adipo-
cytes were stimulated with insulin (100 nM) for 5 min or left untreated. The cell
lysates were then incubated with GST fusion proteins containing the first SH3
domain (SH3A, closest to the N terminus), the middle SH3 domain (SH3B), the
carboxyl-terminal SH3 domain of CAP (SH3C), and the Crk-SH3 domain. The
resulting precipitated proteins were separated by SDS-PAGE and immunoblot-
ted with anti-c-Cbl or anti-Sos antibodies. Molecular mass markers (in kilodal-
tons) are on the left.
FIG. 5. In vivo association of CAP with c-Cbl and Sos. (A) CHO cells trans-
fected with Flag-CAP or the vector alone (PCI) were lysed and immunoprecipi-
tated with anti-CAP or anti-Flag antibodies. Following SDS-PAGE, the immu-
noprecipitates (IP) were immunoblotted with anti-c-Cbl antibodies. (B) CHO
cells transfected with Flag-CAP were lysed and immunoprecipitated with anti-
Sos antibodies. The immunoprecipitates were separated by SDS-PAGE and
immunoblotted with anti-CAP antibodies. WCL, whole-cell lysates. Molecular
mass markers (in kilodaltons) are on the left.
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Lysates of unstimulated or insulin-stimulated 3T3-L1 adipo-
cytes were immunoprecipitated with anti-CAP or anti-c-Crk-II
antibodies as a control. The resulting immunocomplexes were
blotted with anti-c-Cbl antibodies. As shown in Fig. 6 (anti-c-
Cbl blot), c-Cbl coimmunoprecipitated with the endogenous
CAP in quiescent, unstimulated 3T3-L1 adipocytes. Insulin
treatment did not affect this association. In the control exper-
iment, and as we have recently shown (30), after insulin-de-
pendent tyrosine phosphorylation, c-Cbl forms complexes with
endogenous c-Crk. The anti-CAP immunoblotting of the
above-described immunoprecipitates revealed that CAP pro-
teins detected in 3T3-L1 adipocyte cell lysates (Fig. 2B) were
also immunoprecipitated by the anti-CAP antibodies (Fig. 6,
anti-CAP blot). Equal amounts of these proteins were im-
munoprecipitated from unstimulated or insulin-stimulated
3T3-L1 adipocytes. These results show that endogenous c-Cbl
and CAP interact in vivo in a constitutive manner in 3T3-L1
adipocytes. We could not detect any tyrosine phosphorylation
of CAP proteins in unstimulated or insulin-stimulated 3T3-L1
adipocytes (data not shown).
Association of CAP with the insulin receptor in 3T3-L1
adipocytes. Given the predominant expression of CAP in dif-
ferentiated versus undifferentiated 3T3-L1 cells, we examined
whether endogenous CAP could form a complex with the in-
sulin receptor. 3T3-L1 adipocytes were stimulated with and
without insulin for the indicated times, and the cell lysates were
incubated with anti-insulin receptor antibodies. The resulting
immunoprecipitates were separated by SDS-PAGE and were
analyzed by immunoblotting with anti-CAP antibodies. As
shown in Fig. 7A (anti-CAP blot), one major CAP isoform
coimmunoprecipitated with the insulin receptor in unstimu-
lated 3T3-L1 adipocytes. Interestingly, addition of insulin
caused a time-dependent dissociation of the CAP-insulin re-
ceptor complex. After 5 min of insulin stimulation, only a
fraction of CAP was detected in the anti-insulin receptor im-
munoprecipitate. To ensure that the dissociation of CAP from
the insulin receptor is due to insulin stimulation, 3T3-L1 adi-
pocytes were treated with EGF. EGF stimulation had no effect
on the association state of CAP with the insulin receptor, and
the same levels of CAP were detected in the anti-insulin re-
ceptor immunoprecipitates from unstimulated and EGF-stim-
ulated 3T3-L1 adipocytes. The blot was completely stripped of
the anti-CAP antibodies and reprobed with anti-insulin recep-
tor antibodies (Fig. 7A, anti-IR blot). The insulin receptors
were precipitated equally from all samples. Antiphosphoty-
rosine immunoblotting of the whole-cell lysate samples used in
these experiments confirmed that insulin and EGF stimulated
the tyrosine autophosphorylation of the insulin receptor b-sub-
unit and the EGF receptor, respectively (Fig. 7B, anti-pY blot).
The dissociation of CAP from the insulin receptor was not due
to dephosphorylation of the receptor, as it remains tyrosine
phosphorylated during this time. The finding that in 3T3-L1
adipocytes predominantly one form of CAP associates with the
insulin receptor, and that this interaction decreased following
insulin receptor activation, raises the possibility that CAP may
link c-Cbl to the insulin receptor. The functional domains
within CAP and the insulin receptor that mediate these inter-
actions remain to be determined.
Localization of CAP in 3T3-L1 adipocytes. We next analyzed
the subcellular localization of CAP proteins. Differentiated
3T3-L1 cells were treated with or without insulin and then
fractionated into cytosolic and membrane fractions. Immuno-
blotting of the fractions with the anti-CAP antibodies showed
both that CAP proteins are present in the cytosolic and mem-
brane fractions of unstimulated 3T3-L1 adipocytes and that
insulin stimulation did not significantly alter the subcellular
distribution of CAP (Fig. 8, anti-CAP blot). The purity of the
fractions was analyzed with the anti-insulin receptor antibodies
that detected the insulin receptor exclusively in the membrane
fraction (Fig. 8, anti-IR blot), while anti-ERK2 antibodies
were used to detect ERK2 in the cytosolic fraction (Fig. 8,
anti-ERK2 blot). The multiple SH3 domains of CAP may
direct the localization of some CAP to the membrane fraction
FIG. 6. CAP associates with c-Cbl in intact 3T3-L1 adipocytes. 3T3-L1 adi-
pocytes were serum starved for 18 h and then stimulated with insulin (100 nM)
for 5 min or left untreated. The cell lysates were immunoprecipitated with anti-
c-Crk or anti-CAP antibodies. The resulting immunoprecipitates (IP) were sep-
arated by SDS-PAGE and subjected to immunoblotting with anti-c-Cbl antibod-
ies. The blot was then stripped of the anti-c-Cbl antibodies and reprobed with
anti-CAP antibodies. WCL, whole-cell lysates. Molecular mass markers (in kilo-
daltons) are on the left.
FIG. 7. Association of CAP with the insulin receptor in 3T3-L1 adipocytes.
(A) Cell lysates prepared from serum-starved 3T3-L1 adipocytes treated with
insulin (100 nM) for the indicated times or with EGF (100 ng/ml) for 5 min were
immunoprecipitated with anti-insulin receptor (Anti-IR) antibodies. The immu-
noprecipitates (IP) were subjected to SDS-PAGE and immunoblotted with anti-
CAP antibodies. The blot was then stripped of the anti-CAP antibodies and
reprobed with anti-IR antibodies. (B) Equal protein amounts (30 mg per lane) of
the cell lysates used in panel A were directly analyzed by immunoblotting with
antiphosphotyrosine antibodies (anti-pY). The positions of the EGF receptor
(EGFR) and the insulin receptor (IR) are indicated by arrows. WCL, whole-cell
lysates. Molecular mass markers (in kilodaltons) are on the left.
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of the cells, as this motif is often found in cytoskeleton-asso-
ciated proteins (25).
DISCUSSION
Protein tyrosine phosphorylation is an early event in insulin-
initiated intracellular signaling cascades (34, 45). Recently, we
have demonstrated that insulin stimulates the tyrosine phos-
phorylation of the c-Cbl proto-oncogene product, and this
phosphorylation shows specificity for the differentiated adipo-
cyte phenotype. Following insulin stimulation, the tyrosine-
phosphorylated c-Cbl specifically associates with the adapter
c-Crk and the Fyn tyrosine kinase in vivo and in vitro (30).
Because we could not detect c-Cbl tyrosine phosphorylation in
response to insulin in a variety of other cell types expressing
functional insulin receptor (30), we suspected that 3T3-L1
adipocytes might express a specific adapter protein that may be
involved in the tyrosine phosphorylation of c-Cbl.
To search for such novel proteins we used the full-length
c-Cbl as a target protein to screen a 3T3-L1 adipocyte cDNA
library in the yeast two-hybrid system. Multiple, independent
c-DNA inserts, which encoded different fragments of the same
protein were cloned from this library and designated CAP for
c-Cbl-associated protein. These interactions were then verified
in several experiments by using GST fusion proteins and co-
immunoprecipitation. Analysis of the predicted amino acid
sequences of these clones revealed three adjacent SH3 do-
mains at the carboxyl terminus and a novel putative sorbin
homology domain at the N terminus. The structure of CAP
suggests that it may participate in multiple signaling cascades.
cDNA sequencing and Northern blot analysis indicated that
there are multiple splice variants of CAP that may result in a
family of different isoforms. Interestingly, both CAP mRNA
and proteins are expressed predominately in 3T3-L1 adipo-
cytes and not in 3T3-L1 fibroblasts, implying a restricted sig-
naling role for CAP in these cells.
The three SH3 domains of CAP were cloned as a fragment
from the yeast two-hybrid library, suggesting that the associa-
tion of CAP with c-Cbl was SH3 mediated. This was further
suggested by an examination of the proline-rich regions of
c-Cbl, revealing multiple potential SH3 binding motifs (6). In
vitro binding assays with GST fusion proteins containing the
individual SH3 domains of CAP confirmed that the functional
association of CAP with c-Cbl is mediated primarily by the
carboxyl-terminal SH3 domain of CAP. Interestingly, in
3T3-L1 adipocytes, which normally express both CAP and c-
Cbl, CAP and c-Cbl associate in a constitutive manner inde-
pendent of insulin stimulation. The specific tyrosine phosphor-
ylation of c-Cbl and CAP expression in the differentiated
adipocytes suggest that the CAP-c-Cbl complex may have a
specialized signaling function in insulin action in these cells.
The observation that one major CAP isoform associated with
the insulin receptor suggests that at least one role of CAP
might be to facilitate the interaction of c-Cbl with the insulin
receptor, allowing for the phosphorylation of c-Cbl and its
association with c-Crk and Fyn. Indeed, c-Cbl tyrosine phos-
phorylation is observed only in 3T3-L1 adipocytes, which
uniquely express CAP. Moreover, receptor activation leads to
rapid dissociation of the insulin receptor-CAP complex. The
kinetics of the insulin receptor-CAP dissociation parallels the
time course of insulin-stimulated tyrosine phosphorylation of
c-Cbl in these cells (30). The structural requirements for this
interaction remain to be determined.
The c-cbl gene was cloned as the cellular homolog of the
v-cbl oncogene, which is transforming in early B-lineage and
myeloid cells (5, 6). However, overexpression of c-Cbl does not
induce cellular transformation, and the function of the proto-
oncogene product remains unclear. The potential signaling
function of c-Cbl downstream of tyrosine kinases depends on
the association of its proline-rich region with SH3 domain-
containing signaling proteins such as Grb2 and Nck (8, 11, 14,
21, 31) and the tyrosine phosphorylation sites with SH2 do-
main-containing proteins (8, 11, 13, 14, 18, 28, 37). Since Grb2
and Nck are ubiquitous in their expression, CAP with its spe-
cific expression in 3T3-L1 adipocytes may represent a special-
ized component in the signal transduction role of c-Cbl in
these cells. Thus, different pools of c-Cbl may associate with
different proteins forming various signaling complexes, each
with distinct cellular function.
The ability of insulin to stimulate glucose uptake and storage
of glucose as glycogen and lipids is significantly increased after
3T3-L1 differentiation. The expression of many fat cell-specific
genes critical to insulin action is increased during adipocyte
differentiation, such as GLUT4 (10, 17). Thus, changes in the
level of CAP expression and c-Cbl tyrosine phosphorylation
might contribute to increased insulin responsiveness observed
in differentiated 3T3-L1 adipocytes. CAP was also found to
associate with the nucleotide exchange protein Sos. Insulin
treatment of 3T3-L1 adipocytes induces a dissociation of the
CAP-SH3 domain from Sos similar to the dissociation of the
FIG. 8. Subcellular localization of CAP proteins in 3T3-L1 adipocytes. Se-
rum-starved differentiated 3T3-L1 cells were stimulated with and without insulin
(100 nM) for 5 min. Subcellular fractionation was obtained as described in
Materials and Methods, and fractions are identified as C (cytosolic fraction) and
M (membrane fraction). Equal amounts of protein (25 mg per lane) were ana-
lyzed by immunoblotting with anti-CAP, anti-insulin receptor, and anti-ERK2
antibodies. Molecular mass markers (in kilodaltons) are on the left.
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Grb2/Sos complex (44). CAP, CAP/c-Cbl, and CAP/Sos may
represent specific endogenous regulators in insulin-activated
signal transduction pathways in 3T3-L1 adipocytes.
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